Advanced searches left 3/3

Methylation genes Ovarian Cancer - Europe PMC

Summarized by Plex Scholar
Last Updated: 15 November 2021

* If you want to update the article please login/register

Identification of Methylation-Driven Genes Prognosis Signature and Immune Microenvironment in Epithelial Ovarian Cancer

We aimed to identification methylation driven genes included in EOC to establish a prognostic signature for patients with EOC. Methods The methylation, RNA expression and professional information of EOC patients were downloaded and install from UCSC Xena internet site. Outcomes of multivariate and univariate evaluations suggested that the threat rating model was an independent danger aspect for EOC. Analysis of mRNA levels of the six genes in OVCAR3 before and after DAC treatment disclosed that DAC hindered the methylation of six genes, thereby increasing mRNA levels of the six genes. GSEA analysis show that related to the 6 MDGs in the 2 threat score model teams signaling pathways are very closely pertaining to tumor intrusion and transition. There are considerable differences in between both risk rating design groups in terms of immune function, check factor and TMB.

Source link: https://europepmc.org/article/PPR/PPR406767


A Risk Score Model Incorporating Three m6A RNA Methylation Regulators and a Related Network of miRNAs-m6A Regulators-m6A Target Genes to Predict the Prognosis of Patients With Ovarian Cancer.

In the present study, we obtained the genome datasets of OC from GDC and GTEx data source and analyzed the mRNA levels of 21 essential m6A regulators in OC and regular human ovarian tissues. Especially, the 5-year survival rate of patients with OC offering low VIRMA expression or high HNRNPA2B1 expression was higher than that of the controls. Next, a threat score design based on the 3 picked m6A regulatory authorities was developed by executing a LASSO regression evaluation, and the moderate accuracy of the danger rating model to forecast the prognosis of patients with OC was checked out by doing ROC curve, nomogram, and univariate and multivariate Cox regression evaluations.

Source link: https://europepmc.org/article/MED/34631700


Development and Validation of a Prognostic Nomogram Based on DNA Methylation-Driven Genes for Patients With Ovarian Cancer.

This research aimed to determine DNA methylated-differentially revealed genes and develop a methylation-driven genetics version to review the prognosis of ovarian cancer. Techniques: DNA methylation and mRNA expression accounts of OC patients were downloaded and install from The Cancer Genome Atlas, Genotype-Tissue Expression, and Gene Expression Omnibus databases. We made use of the R plan MethylMix to recognize DNA methylation-regulated DEGs and developed a prognostic signature utilizing LASSO Cox regression. Outcomes: We determined 56 methylation-related DEGs and constructed a prognostic danger trademark with 4 genes according to the LASSO Cox regression algorithm. The joint survival evaluation of DNA methylation and mRNA expression demonstrated that the two genes might function as independent prognostic biomarkers for OS in OC. Conclusion: The well established qualitative danger rating version was located to be robust for assessing customized diagnosis of OC and in assisting therapy.

Source link: https://europepmc.org/article/MED/34567062

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions